Aseptic bone-flap resorption after cranioplasty - incidence and risk factors.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 10 08 2019
accepted: 05 01 2020
entrez: 31 1 2020
pubmed: 31 1 2020
medline: 15 4 2020
Statut: epublish

Résumé

One of the common complications occurring after cranioplasty (CP) is aseptic bone-flap resorption (ABFR). Reoperation necessary because of the development of ABFR can lead to unfavorable complications during subsequent surgery using a synthetic skull implant, and also necessarily leads to higher costs. The aim of this study is to identify prognostic factors that may help to predict the development of ABFR. In this study, 303 CP surgeries performed between 2002 and 2017 were examined retrospectively to identify factors predicting the occurrence of ABFR. A number of these factors (e.g., time lapse between decompressive craniectomy (DC) and CP, bone-flap size, specific laboratory signs, and the reason for the original DC) were analyzed as possibly influencing the risk of developing ABFR. ABFR of an autologous bone flap that subsequently required a CP with synthetic skull implants occurred in 10 of 303 patients (3.0%). CP timing and patients' Karnofsky Performance Scores (KPS) (p = 0.008; p = 0.012) were identified as significant factors with an impact on the development of ABRF. Age did not reveal a significant value, but statistical analysis shows a clear trend. The younger the age, the more likely it was that an ABFR would develop. The risk of ABFR lessens the longer the period of time elapsed between DC and CP. Age does not reveal a significant value, but statistical analysis shows that there is a clear trend.

Identifiants

pubmed: 31999739
doi: 10.1371/journal.pone.0228009
pii: PONE-D-19-22619
pmc: PMC6992164
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0228009

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Clin Neurol Neurosurg. 2014 May;120:64-7
pubmed: 24731578
Acta Neurochir (Wien). 2014 Apr;156(4):813-24
pubmed: 24532225
J Neurosurg. 2016 Mar;124(3):710-5
pubmed: 26406796
J Neurosurg. 2013 May;118(5):1141-7
pubmed: 23451904
J Neurosurg. 2017 Dec;127(6):1449-1456
pubmed: 28186447
Zentralbl Neurochir. 2007 Nov;68(4):182-9
pubmed: 17966077
Neurocrit Care. 2014 Feb;20(1):91-7
pubmed: 23975615
J Neurosurg. 2004 Feb;100(2 Suppl Pediatrics):163-8
pubmed: 14758944
Acta Neurochir (Wien). 2019 Jan;161(1):25-31
pubmed: 30511143
J Neurosurg. 2013 Jan;118(1):109-14
pubmed: 23140156
Acta Neurochir (Wien). 2019 Mar;161(3):483-491
pubmed: 30617716
Plast Reconstr Surg. 2012 Nov;130(5):1110-7
pubmed: 23096611
J Clin Neurosci. 2017 Aug;42:81-83
pubmed: 28431953
Neurosurgery. 2018 Mar 1;82(3):278-288
pubmed: 28419358
Clin Neurol Neurosurg. 2014 Sep;124:85-9
pubmed: 25019457
Brain Inj. 2015;29(13-14):1654-60
pubmed: 26513495
World Neurosurg. 2018 Jul;115:e111-e118
pubmed: 29626687
Pediatr Neurosurg. 1997 Jan;26(1):33-5
pubmed: 9361115
J Clin Neurosci. 2016 Nov;33:39-51
pubmed: 27499122
Biom J. 2008 Jun;50(3):419-30
pubmed: 18435502
Scand J Trauma Resusc Emerg Med. 2015 Oct 06;23:75
pubmed: 26437934
World Neurosurg. 2016 Dec;96:510-515
pubmed: 27647038
World Neurosurg. 2014 Sep-Oct;82(3-4):e531-4
pubmed: 23298668
World Neurosurg. 2018 Apr;112:e645-e651
pubmed: 29374612
J Neurosurg. 2018 Dec 1;129(6):1604-1610
pubmed: 29303450
J Neurosurg. 2018 Jun;128(6):1648-1652
pubmed: 28799868
Acta Neurochir (Wien). 2012 Jun;154(6):1055-62
pubmed: 22527574
J Craniofac Surg. 2012 Nov;23(6):1802-4
pubmed: 23147342
Neurosurgery. 1979 Jan;4(1):18-29
pubmed: 450211
J Neurotrauma. 2013 Jan 15;30(2):91-5
pubmed: 22970998
World Neurosurg. 2017 Jul;103:686-693
pubmed: 28434961
Acta Neurochir (Wien). 2015 Feb;157(2):275-80
pubmed: 25534126
Clin Neurol Neurosurg. 2015 Sep;136:33-40
pubmed: 26056810
Neurosurgery. 2003 Mar;52(3):591-6; discussion 595-6
pubmed: 12590683
Rev Neurol (Paris). 2013 Mar;169(3):240-8
pubmed: 23084153
Craniomaxillofac Trauma Reconstr. 2015 Sep;8(3):190-7
pubmed: 26269726
J Neurosurg Pediatr. 2013 May;11(5):526-32
pubmed: 23473303

Auteurs

Ali Rashidi (A)

Department of Neurosurgery, Medical Faculty, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.

I Erol Sandalcioglu (IE)

Department of Neurosurgery, Medical Faculty, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.

Michael Luchtmann (M)

Department of Neurosurgery, Medical Faculty, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH